Home Your basket
• External otitis...
   Price 8.50 €
• Evaluation of rhinologic ...
   Price 10.50 €
• Benign positional vertigo...
   Price 8.50 €
• Non-traumatic nasal septa...
   Price 8.50 €
• Persistent stapedial arte...
   Price 5.50 €
• Surgery of mucocele of th...
   Price 10.50 €
• An unusual case of intrat...
   Price 5.50 €
• Far-advanced otosclerosis...
   Price 10.50 €
• Benign paroxysmal positio...
   Price 5.50 €
• Therapeutic management of...
   Price 10.50 €
• Orbital decompression in ...
   Price 10.50 €
• Lateral semicircular cana...
   Price 10.50 €
• Covering of parotid and c...
   Price 14.00 €
• Otosclerosis among patien...
   Price 10.50 €
• Surgical procedure in fir...
   Price 8.50 €
• Surgery for hyperthyroidi...
   Price 5.50 €
• Speech intelligibility in...
   Price 10.50 €
• Abscess tonsillectomy for...
   Price 10.50 €
• Free novascularized bone ...
   Price 15.00 €
• Implementation of the Eur...
   Price 10.50 €
• Preliminary experimental ...
   Price 10.50 €
• Diagnosis and treatment o...
   Price 10.50 €
• Rhinolithiasis: Review ab...
   Price 5.50 €
• Early PTH assay after tot...
   Price 10.50 €
• Prognostic value of mandi...
   Price 10.50 €
• A single appointment with...
   Price 8.50 €
• Hearing loss and vestibul...
   Price 10.50 €
• Post-traumatic carotid ca...
   Price 8.50 €
• Time-intensity trade of b...
   Price 10.50 €
• Association of Bezold’s a...
   Price 8.50 €
• Adult laryngeal cavernous...
   Price 5.50 €
• Therapeutic education of ...
   Price 12.50 €
• Tuberculosis of the parot...
   Price 5.50 €
• Efficacy and safety of mo...
   Price 10.50 €
• Cervical liposuction: A r...
   Price 10.50 €
• Delayed labyrinthine fist...
   Price 10.50 €
• Primary nasal tuberculosi...
   Price 5.50 €

Total Order 344.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2000 o

LARYNGOLOGY

Evaluation of the primary tumour and the metastatic lymph node with or without extracapsular spread by means of argyrophillic nucleolar regions (AgNOR)


Authors : C. Bilgen, S. Sarioglu, K. Ceryan (Izmir)

Ref. : Rev Laryngol Otol Rhinol. 2000;121,3:155-159.

Article published in english
Downloadable PDF document english



Summary : Though TNM staging is the most popular clinical system for defining the prognosis of Head and Neck Squamous Cell Carcinoma (HNSCC), different clinical trials of the tumours with the same TNM stage have caused doubts about this system. Extra Capsular Spread (ECS) in a metastatic lymph node is one of the recently defined prognostic factors in HNSCC. The hypothesis of this study was to assess the relationship between the primary tumour of laryngeal and oral cavity squamous cell carcinoma and the metastatic lymph nodes with and without ECS. The argyrophillic Nucleolar Organiser Regions (AgNOR) count was used as an index of the grade of malignancy of the neoplastic tissue. As a result, significantly higher AgNOR counts were obtained in the metastatic lymph nodes with ECS than in the primary tumours, while the lowest AgNOR counts were found in the metastatic lymph nodes without ECS. However, when primary tumours of the metastatic lymph nodes with ECS and the primary tumours of the metastatic lymph nodes without ECS were compared, no significant difference was found.

Price : 5.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE